Lisata Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Lisata Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is €-0.68. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -5.26M	$ -6.36M	$ -6.19M	$ -6.55M	$ -37.72M
EBITDA	$ -5.50M	$ -6.57M	$ -6.31M	$ -6.61M	$ -37.71M
Net Income Common Stockholders	$ -5.26M	$ -4.03M	$ -6.19M	$ -5.99M	$ -37.38M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 54.39M	$ 57.63M	$ 61.09M	$ 69.23M	$ 75.53M
Total Assets	$ 58.09M	$ 62.37M	$ 66.33M	$ 73.03M	$ 78.53M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 548.00K
Net Debt	$ -54.39M	$ -57.63M	$ -61.09M	$ -69.23M	$ -74.98M
Total Liabilities	$ 5.38M	$ 4.65M	$ 5.62M	$ 6.71M	$ 6.76M
Stockholders Equity	$ 52.96M	$ 57.97M	$ 60.96M	$ 66.58M	$ 72.03M
Cash Flow	-
Free Cash Flow	$ -3.58M	$ -4.18M	$ -8.20M	$ -6.49M	$ -4.02M
Operating Cash Flow	$ -3.58M	$ -4.18M	$ -8.20M	$ -6.47M	$ -4.00M
Investing Cash Flow	$ 12.25M	$ -725.00K	$ 4.29M	$ 7.11M	$ 2.26M
Financing Cash Flow	$ -6.00K	$ 452.00K	$ -85.00K	$ 14.00K	$ -99.00K

Currency in USD

Lisata Therapeutics Earnings and Revenue History

Income Statement >

Lisata Therapeutics Debt to Assets

Balance Sheet >

Lisata Therapeutics Cash Flow

Cash Flow >

Lisata Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing